Literature DB >> 33649100

Roxadustat for Renal Anemia in ESRD from PKD Patients: Is It Safe Enough?

Fei Liu1, Jingjing Wang1, Qing Ye2, Haidong Fu1, Jianhua Mao3.   

Abstract

Entities:  

Keywords:  anemia chronic kidney disease; polycystic kidney disease

Year:  2021        PMID： 33649100      PMCID： PMC8017543          DOI： 10.1681/ASN.2020111664

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  4 in total

Review 1.  Role of oxygen and the HIF-pathway in polycystic kidney disease.

Authors:  Bjoern Buchholz; Kai-Uwe Eckardt
Journal:  Cell Signal       Date:  2020-01-02       Impact factor: 4.315

2.  HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease.

Authors:  Andre Kraus; Dorien J M Peters; Bernd Klanke; Alexander Weidemann; Carsten Willam; Gunnar Schley; Karl Kunzelmann; Kai-Uwe Eckardt; Bjoern Buchholz
Journal:  Kidney Int       Date:  2018-08-30       Impact factor: 10.612

3.  Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.

Authors:  Tadao Akizawa; Manabu Iwasaki; Yusuke Yamaguchi; Yoshikatsu Majikawa; Michael Reusch
Journal:  J Am Soc Nephrol       Date:  2020-06-03       Impact factor: 10.121

4.  Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Tadao Akizawa; Manabu Iwasaki; Tetsuro Otsuka; Michael Reusch; Toshihiro Misumi
Journal:  Adv Ther       Date:  2019-04-05       Impact factor: 3.845
  4 in total
  5 in total

Review 1.  Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Allison Jaure; Elisabeth M Hodson; Marinella Ruospo; Tess E Cooper; Deirdre Hahn; Valeria M Saglimbene; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-08-25

Review 2.  Sodium-glucose cotransporter inhibition in polycystic kidney disease: fact or fiction.

Authors:  Baris Afsar; Rengin Elsurer Afsar; Atalay Demiray; Sevval Altay; Hakan Korkmaz; Abdulmecit Yildiz; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Clin Kidney J       Date:  2022-01-31

3.  Authors' Reply.

Authors:  Tadao Akizawa; Manabu Iwasaki; Yusuke Yamaguchi; Yoshikatsu Majikawa; Michael Reusch
Journal:  J Am Soc Nephrol       Date:  2021-03-01       Impact factor: 10.121

Review 4.  Roxadustat: Not just for anemia.

Authors:  Xiaoyu Zhu; Lili Jiang; Xuejiao Wei; Mengtuan Long; Yujun Du
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

5.  Risk of infection in roxadustat treatment for anemia in patients with chronic kidney disease: A systematic review with meta-analysis and trial sequential analysis.

Authors:  Shan Chong; Qiufen Xie; Tiantian Ma; Qian Xiang; Ying Zhou; Yimin Cui
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.